Laura Safar, MD, on Neuropsychiatric Disorders Among Patients With Multiple Sclerosis: Key Clinical Takeaways

In this video, Laura T. Safar, MD, addresses the impact of neuropsychiatric disorders on quality of life among patients with multiple sclerosis, and the importance of monitoring the prevalence of depression, anxiety, and cognitive disorders in this patient population. She recently gave a talk on this topic at the Consortium for Multiple Sclerosis Centers Virtual Meeting.


  • Safar LT. Use of psychotropics in MS: antidepressants, antianxiety agents, mood stabilizers, hypnotics, antipsychotics, and cognitive enhancers. Talk presented at: Consortium of Multiple Sclerosis Centers 2020 Virtual Meeting; May 28, 2020.


Laura T. Safar, MD, is an assistant professor of psychiatry at Harvard Medical School and vice chair of psychiatry at Lahey Hospital & Medical Center in Massachusetts.

    Submit Feedback